Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.

OBJECTIVES:The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil. DESIGN:Analytical model for decision making, characterized...

Full description

Bibliographic Details
Main Authors: Rafaela Borge Loureiro, Ethel Leonor Noia Maciel, Rosangela Caetano, Renata Lyrio Peres, Geisa Fregona, Jonathan E Golub, José Ueleres Braga
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2019-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0225197
_version_ 1819259600596107264
author Rafaela Borge Loureiro
Ethel Leonor Noia Maciel
Rosangela Caetano
Renata Lyrio Peres
Geisa Fregona
Jonathan E Golub
José Ueleres Braga
author_facet Rafaela Borge Loureiro
Ethel Leonor Noia Maciel
Rosangela Caetano
Renata Lyrio Peres
Geisa Fregona
Jonathan E Golub
José Ueleres Braga
author_sort Rafaela Borge Loureiro
collection DOAJ
description OBJECTIVES:The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil. DESIGN:Analytical model for decision making, characterized by cost-effectiveness analysis. SETTING:Primary Care Level, considering primary health care workers in Brazil. PARTICIPANTS:An analytical model for decision making, characterized by a tree of probabilities of events, was developed considering a hypothetical cohort of 10,000 primary health care workers, using the software TreeAge Pro™ 2013 to simulate the clinical and economic impacts of new diagnostic technology (QuantiFERON®-TB Gold in-Tube) versus the traditional tuberculin skin test. METHODS:This model simulated five diagnostic strategies for LTBI in primary health care workers (HCW) in Brazil: tuberculin skin testing using ≥5 mm cut-off, tuberculin skin testing ≥10 mm cut-off, QuantiFERON®-TB Gold in-Tube, tuberculin skin testing using ≥5 mm cut-off confirmed by QuantiFERON®-TB Gold In-Tube if TST positive, tuberculin skin testing using ≥10 mm cut-off confirmed by QuantiFERON®-TB Gold In-Tube if TST positive. PRIMARY AND SECONDARY OUTCOME MEASURES:The outcome measures are the number of individuals correctly classified by the test and the number of Tuberculosis cases avoided. RESULTS:The most cost-effective strategy was the tuberculin skin test considering ≥10mm cut-off. The isolated use of the QuantiFERON®-TB Gold In-Tube revealed the strategy of lower efficiency with incremental cost-effectiveness ratio (ICER) of US$ 146.05 for each HCW correctly classified by the test. CONCLUSIONS:The tuberculin skin test using ≥10 mm cut-off was the most cost-effective strategy in the diagnosis of Latent Tuberculosis Infection in primary health care works in Brazil.
first_indexed 2024-12-23T19:12:35Z
format Article
id doaj.art-aca8d0277bb5454790285548c7faf7e4
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-23T19:12:35Z
publishDate 2019-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-aca8d0277bb5454790285548c7faf7e42022-12-21T17:34:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011411e022519710.1371/journal.pone.0225197Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.Rafaela Borge LoureiroEthel Leonor Noia MacielRosangela CaetanoRenata Lyrio PeresGeisa FregonaJonathan E GolubJosé Ueleres BragaOBJECTIVES:The goal of this study was to perform a cost-effectiveness analysis from the public health system perspective, comparing five strategies for Latent Tuberculosis Infection (LTBI) diagnosis in primary health care workers in Brazil. DESIGN:Analytical model for decision making, characterized by cost-effectiveness analysis. SETTING:Primary Care Level, considering primary health care workers in Brazil. PARTICIPANTS:An analytical model for decision making, characterized by a tree of probabilities of events, was developed considering a hypothetical cohort of 10,000 primary health care workers, using the software TreeAge Pro™ 2013 to simulate the clinical and economic impacts of new diagnostic technology (QuantiFERON®-TB Gold in-Tube) versus the traditional tuberculin skin test. METHODS:This model simulated five diagnostic strategies for LTBI in primary health care workers (HCW) in Brazil: tuberculin skin testing using ≥5 mm cut-off, tuberculin skin testing ≥10 mm cut-off, QuantiFERON®-TB Gold in-Tube, tuberculin skin testing using ≥5 mm cut-off confirmed by QuantiFERON®-TB Gold In-Tube if TST positive, tuberculin skin testing using ≥10 mm cut-off confirmed by QuantiFERON®-TB Gold In-Tube if TST positive. PRIMARY AND SECONDARY OUTCOME MEASURES:The outcome measures are the number of individuals correctly classified by the test and the number of Tuberculosis cases avoided. RESULTS:The most cost-effective strategy was the tuberculin skin test considering ≥10mm cut-off. The isolated use of the QuantiFERON®-TB Gold In-Tube revealed the strategy of lower efficiency with incremental cost-effectiveness ratio (ICER) of US$ 146.05 for each HCW correctly classified by the test. CONCLUSIONS:The tuberculin skin test using ≥10 mm cut-off was the most cost-effective strategy in the diagnosis of Latent Tuberculosis Infection in primary health care works in Brazil.https://doi.org/10.1371/journal.pone.0225197
spellingShingle Rafaela Borge Loureiro
Ethel Leonor Noia Maciel
Rosangela Caetano
Renata Lyrio Peres
Geisa Fregona
Jonathan E Golub
José Ueleres Braga
Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
PLoS ONE
title Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
title_full Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
title_fullStr Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
title_full_unstemmed Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
title_short Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
title_sort cost effectiveness of quantiferon tb gold in tube versus tuberculin skin test for diagnosis and treatment of latent tuberculosis infection in primary health care workers in brazil
url https://doi.org/10.1371/journal.pone.0225197
work_keys_str_mv AT rafaelaborgeloureiro costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT ethelleonornoiamaciel costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT rosangelacaetano costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT renatalyrioperes costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT geisafregona costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT jonathanegolub costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil
AT joseueleresbraga costeffectivenessofquantiferontbgoldintubeversustuberculinskintestfordiagnosisandtreatmentoflatenttuberculosisinfectioninprimaryhealthcareworkersinbrazil